GLYCOPYRROLATE INJECTION MULTIDOSE 4 MG / 20 ML
GLYCOPYRROLATE : 4 MG / 20 ML · DIN 02479273 · MONT-PHARMA INC
Health Canada status: APPROVED
What is GLYCOPYRROLATE INJECTION MULTIDOSE?
GLYCOPYRROLATE INJECTION MULTIDOSE 4 MG / 20 ML contains GLYCOPYRROLATE : 4 MG / 20 ML. It is listed in the Health Canada Drug Product Database under DIN 02479273, held by MONT-PHARMA INC, supplied as SOLUTION for INTRAVENOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as approved, status dated 23-Jul-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02479273 |
|---|---|
| Brand name | GLYCOPYRROLATE INJECTION MULTIDOSE |
| Generic / active ingredient | GLYCOPYRROLATE : 4 MG / 20 ML |
| Manufacturer | MONT-PHARMA INC |
| Strength | 4 MG / 20 ML |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS ; INTRAMUSCULAR |
| Schedule | Ethical |
| ATC code | A03AB02 GLYCOPYRRONIUM |
| AHFS class | 12:08.08 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 23-Jul-2018 |
What can be used instead?
Other Canadian products sharing ATC code A03AB02 GLYCOPYRRONIUM. 8 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CUVPOSA | 1 MG / 5 ML | SOLUTION | MEDEXUS PHARMACEUTICALS INC. | MARKETED | DIN 02469332 |
| GLYCOPYRROLATE INJECTION MULTIDOSE | 0.2 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02382849 |
| GLYCOPYRROLATE INJECTION USP | 0.2 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02039508 |
| GLYCOPYRROLATE INJECTION USP | 0.2 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02532379 |
| GLYCOPYRROLATE INJECTION USP | 0.2 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02513749 |
| GLYCOPYRROLATE INJECTION USP | 0.2 MG / 1 ML | SOLUTION | STERIMAX INC | MARKETED | DIN 02473879 |
| GLYCOPYRROLATE INJECTION USP | 0.4 MG / 2 ML | SOLUTION | STERIMAX INC | MARKETED | DIN 02473895 |
| GLYCOPYRROLATE INJECTION USP | 4 MG / 20 ML | SOLUTION | STERIMAX INC | MARKETED | DIN 02473887 |
| GLYCOPYRROLATE INJECTION | 0.2 MG | SOLUTION | JUNO PHARMACEUTICALS CORP. | CANCELLED PRE MARKET | DIN 02539160 |
| GLYCOPYRROLATE INJECTION MULTIDOSE | 0.2 MG | SOLUTION | JUNO PHARMACEUTICALS CORP. | CANCELLED PRE MARKET | DIN 02539276 |
Who else supplies GLYCOPYRRONIUM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. GLYCOPYRRONIUM appears in 33 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.